Compare BWMX & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BWMX | PSNL |
|---|---|---|
| Founded | 1995 | 2011 |
| Country | Mexico | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 699.4M | 729.1M |
| IPO Year | 2019 | 2019 |
| Metric | BWMX | PSNL |
|---|---|---|
| Price | $16.08 | $6.40 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | ★ $27.83 | $12.20 |
| AVG Volume (30 Days) | 91.7K | ★ 2.2M |
| Earning Date | 04-23-2026 | 05-07-2026 |
| Dividend Yield | ★ 9.11% | N/A |
| EPS Growth | N/A | ★ 33.58 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $69,648,000.00 |
| Revenue This Year | $18.17 | $15.34 |
| Revenue Next Year | $25.68 | $41.46 |
| P/E Ratio | $12.54 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.00 | $3.84 |
| 52 Week High | $19.79 | $11.50 |
| Indicator | BWMX | PSNL |
|---|---|---|
| Relative Strength Index (RSI) | 34.38 | 52.55 |
| Support Level | $16.09 | $5.81 |
| Resistance Level | $19.43 | $9.64 |
| Average True Range (ATR) | 0.58 | 0.52 |
| MACD | -0.09 | 0.14 |
| Stochastic Oscillator | 9.77 | 59.28 |
Betterware de Mexico SAPI de CV is a direct-to-consumer selling company. The company operates through two business segments: the home organization products (Betterware segment or BWM segment) and the beauty and personal care products (B and PC) (JAFRA segment). The Betterware's segment is divided in seven categories of the home organization: Kitchen and food preservation, Home solutions, Bedroom, Bathroom, Laundry & Cleaning, Tech & mobility and wellness. The JAFRA's segment is divided into four categories beauty and personal care: fragrance, color (cosmetics), skin care and toiletries. The company generates a majority of its revenue from the Beauty and personal care (B&PC) (JAFRA segment). Geographically, key revenue for the company is derived from Mexico.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.